Farhad Najmeddin

10PUBLICATIONS
31CO-AUTHORS
Cardiology (incl. cardiovascular diseases)PharmacogenomicsIntensive careIndustrial molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 04, 2026
Impaired clopidogrel activation due to CYP2C19 phenoconversion after mild acute ischaemic stroke.

|Jul 28, 2025
Perioperative Use of Pregabalin vs. Duloxetine for Pain Management of Knee Fracture Surgery: A Double-Blind Randomized Clinical Trial.

Mohadeseh Masoumi, Mohammad Soleimani, Tara Shekari

|Aug 07, 2024
Comparison of the Areas Under the Curve of Vancomycin Continuous vs. Intermittent Infusion in Critically Ill Pediatrics: A Randomized Clinical Trial.

Baran Roshan N S, Bahador Mirrahimi, Farhad Najmeddin

|May 08, 2024
Intragastric Botulinum Toxin Injection and Botulism: An Alarm for Clinicians.

Mojtaba Mojtahedzadeh, Farhad Najmeddin, Elham Pourheidar

|Sep 07, 2022
Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection.

Hossein Karballaei-Mirzahosseini, Romina Kaveh-Ahangaran, Bita Shahrami

|Jul 11, 2022
LipoxinA4 as a Potential Prognostic Marker of COVID-19.

Farzaneh Jamali, Bita Shahrami, Amirmahdi Mojtahedzadeh

Pageof 2

Frequent Collaborators

5 joint publications

Bita Shahrami

5 joint publications

Mojtaba Mojtahedzadeh

2 joint publications

Mohammad Reza Rouini

2 joint publications

Atabak Najafi